Source: United States & Canada – South China Morning PostOutside advisers to the US Food and Drug Administration on Friday unanimously recommended the agency authorise a second shot of Johnson & Johnson’s Covid-19 vaccine for all recipients of the one-dose inoculation.The agency is also considering lowering the recommended age for booster shots of the Pfizer/BioNTech vaccine to people as young as 40, FDA official Dr Peter Marks told the advisory panel.The FDA’s Vaccines and Related Biological Products Advisory Committee backed the shots for all J&J…Read More